 | • レポートコード：MRC2-11QY08907 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はPET放射性医薬品のグローバル市場について調査・分析したレポートです。種類別（F-18、Ru-82、その他）市場規模、用途別（腫瘍学、心臓病学、神経学、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別PET放射性医薬品の競争状況、市場シェア ・世界のPET放射性医薬品市場：種類別市場規模 2015年-2020年（F-18、Ru-82、その他） ・世界のPET放射性医薬品市場：種類別市場規模予測 2021年-2026年（F-18、Ru-82、その他） ・世界のPET放射性医薬品市場：用途別市場規模 2015年-2020年（腫瘍学、心臓病学、神経学、その他） ・世界のPET放射性医薬品市場：用途別市場規模予測 2021年-2026年（腫瘍学、心臓病学、神経学、その他） ・北米のPET放射性医薬品市場分析：米国、カナダ ・ヨーロッパのPET放射性医薬品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのPET放射性医薬品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のPET放射性医薬品市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのPET放射性医薬品市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Cardinal Health Inc. (U.S.)、Mallinckrodt plc (Ireland)、GE Healthcare (U.K.)、Lantheus Medical Imaging, Inc. (U.S.)、Bayer AG (Germany)、Bracco Imaging S.p.A (Italy)、Eczacibasi-Monrol Nuclear Products (Turkey)、Nordion, Inc. (Canada)、Advanced Accelerator Applications S.A. (France)、IBA Molecular Imaging (Belgium) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global PET Radiopharmaceuticals Market
The global PET Radiopharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global PET Radiopharmaceuticals Scope and Market Size
PET Radiopharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PET Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the PET Radiopharmaceuticals market is segmented into
F-18
Ru-82
Others
Segment by Application, the PET Radiopharmaceuticals market is segmented into
Oncology
Cardiology
Neurology
Others
Regional and Country-level Analysis
The PET Radiopharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the PET Radiopharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and PET Radiopharmaceuticals Market Share Analysis
PET Radiopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in PET Radiopharmaceuticals business, the date to enter into the PET Radiopharmaceuticals market, PET Radiopharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
1 Study Coverage
1.1 PET Radiopharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key PET Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Type
1.4.2 F-18
1.4.3 Ru-82
1.4.4 Others
1.5 Market by Application
1.5.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Neurology
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global PET Radiopharmaceuticals Market Size, Estimates and Forecasts
2.1.1 Global PET Radiopharmaceuticals Revenue 2015-2026
2.1.2 Global PET Radiopharmaceuticals Sales 2015-2026
2.2 Global PET Radiopharmaceuticals, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global PET Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global PET Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global PET Radiopharmaceuticals Competitor Landscape by Players
3.1 PET Radiopharmaceuticals Sales by Manufacturers
3.1.1 PET Radiopharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 PET Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.2 PET Radiopharmaceuticals Revenue by Manufacturers
3.2.1 PET Radiopharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 PET Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global PET Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by PET Radiopharmaceuticals Revenue in 2019
3.2.5 Global PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 PET Radiopharmaceuticals Price by Manufacturers
3.4 PET Radiopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 PET Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers PET Radiopharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into PET Radiopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.1.1 Global PET Radiopharmaceuticals Sales by Type (2015-2020)
4.1.2 Global PET Radiopharmaceuticals Revenue by Type (2015-2020)
4.1.3 PET Radiopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
4.2 Global PET Radiopharmaceuticals Market Size Forecast by Type (2021-2026)
4.2.1 Global PET Radiopharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global PET Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 PET Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global PET Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global PET Radiopharmaceuticals Market Size by Application (2015-2020)
5.1.1 Global PET Radiopharmaceuticals Sales by Application (2015-2020)
5.1.2 Global PET Radiopharmaceuticals Revenue by Application (2015-2020)
5.1.3 PET Radiopharmaceuticals Price by Application (2015-2020)
5.2 PET Radiopharmaceuticals Market Size Forecast by Application (2021-2026)
5.2.1 Global PET Radiopharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global PET Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global PET Radiopharmaceuticals Price Forecast by Application (2021-2026)
6 North America
6.1 North America PET Radiopharmaceuticals by Country
6.1.1 North America PET Radiopharmaceuticals Sales by Country
6.1.2 North America PET Radiopharmaceuticals Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America PET Radiopharmaceuticals Market Facts & Figures by Type
6.3 North America PET Radiopharmaceuticals Market Facts & Figures by Application
7 Europe
7.1 Europe PET Radiopharmaceuticals by Country
7.1.1 Europe PET Radiopharmaceuticals Sales by Country
7.1.2 Europe PET Radiopharmaceuticals Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe PET Radiopharmaceuticals Market Facts & Figures by Type
7.3 Europe PET Radiopharmaceuticals Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific PET Radiopharmaceuticals by Region
8.1.1 Asia Pacific PET Radiopharmaceuticals Sales by Region
8.1.2 Asia Pacific PET Radiopharmaceuticals Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific PET Radiopharmaceuticals Market Facts & Figures by Type
8.3 Asia Pacific PET Radiopharmaceuticals Market Facts & Figures by Application
9 Latin America
9.1 Latin America PET Radiopharmaceuticals by Country
9.1.1 Latin America PET Radiopharmaceuticals Sales by Country
9.1.2 Latin America PET Radiopharmaceuticals Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America PET Radiopharmaceuticals Market Facts & Figures by Type
9.3 Central & South America PET Radiopharmaceuticals Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa PET Radiopharmaceuticals by Country
10.1.1 Middle East and Africa PET Radiopharmaceuticals Sales by Country
10.1.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa PET Radiopharmaceuticals Market Facts & Figures by Type
10.3 Middle East and Africa PET Radiopharmaceuticals Market Facts & Figures by Application
11 Company Profiles
11.1 Cardinal Health Inc. (U.S.)
11.1.1 Cardinal Health Inc. (U.S.) Corporation Information
11.1.2 Cardinal Health Inc. (U.S.) Description and Business Overview
11.1.3 Cardinal Health Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Products Offered
11.1.5 Cardinal Health Inc. (U.S.) Related Developments
11.2 Mallinckrodt plc (Ireland)
11.2.1 Mallinckrodt plc (Ireland) Corporation Information
11.2.2 Mallinckrodt plc (Ireland) Description and Business Overview
11.2.3 Mallinckrodt plc (Ireland) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Products Offered
11.2.5 Mallinckrodt plc (Ireland) Related Developments
11.3 GE Healthcare (U.K.)
11.3.1 GE Healthcare (U.K.) Corporation Information
11.3.2 GE Healthcare (U.K.) Description and Business Overview
11.3.3 GE Healthcare (U.K.) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Products Offered
11.3.5 GE Healthcare (U.K.) Related Developments
11.4 Lantheus Medical Imaging, Inc. (U.S.)
11.4.1 Lantheus Medical Imaging, Inc. (U.S.) Corporation Information
11.4.2 Lantheus Medical Imaging, Inc. (U.S.) Description and Business Overview
11.4.3 Lantheus Medical Imaging, Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Products Offered
11.4.5 Lantheus Medical Imaging, Inc. (U.S.) Related Developments
11.5 Bayer AG (Germany)
11.5.1 Bayer AG (Germany) Corporation Information
11.5.2 Bayer AG (Germany) Description and Business Overview
11.5.3 Bayer AG (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Products Offered
11.5.5 Bayer AG (Germany) Related Developments
11.6 Bracco Imaging S.p.A (Italy)
11.6.1 Bracco Imaging S.p.A (Italy) Corporation Information
11.6.2 Bracco Imaging S.p.A (Italy) Description and Business Overview
11.6.3 Bracco Imaging S.p.A (Italy) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Products Offered
11.6.5 Bracco Imaging S.p.A (Italy) Related Developments
11.7 Eczacibasi-Monrol Nuclear Products (Turkey)
11.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information
11.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Description and Business Overview
11.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Products Offered
11.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Related Developments
11.8 Nordion, Inc. (Canada)
11.8.1 Nordion, Inc. (Canada) Corporation Information
11.8.2 Nordion, Inc. (Canada) Description and Business Overview
11.8.3 Nordion, Inc. (Canada) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Products Offered
11.8.5 Nordion, Inc. (Canada) Related Developments
11.9 Advanced Accelerator Applications S.A. (France)
11.9.1 Advanced Accelerator Applications S.A. (France) Corporation Information
11.9.2 Advanced Accelerator Applications S.A. (France) Description and Business Overview
11.9.3 Advanced Accelerator Applications S.A. (France) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Products Offered
11.9.5 Advanced Accelerator Applications S.A. (France) Related Developments
11.10 IBA Molecular Imaging (Belgium)
11.10.1 IBA Molecular Imaging (Belgium) Corporation Information
11.10.2 IBA Molecular Imaging (Belgium) Description and Business Overview
11.10.3 IBA Molecular Imaging (Belgium) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Products Offered
11.10.5 IBA Molecular Imaging (Belgium) Related Developments
11.1 Cardinal Health Inc. (U.S.)
11.1.1 Cardinal Health Inc. (U.S.) Corporation Information
11.1.2 Cardinal Health Inc. (U.S.) Description and Business Overview
11.1.3 Cardinal Health Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Products Offered
11.1.5 Cardinal Health Inc. (U.S.) Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 PET Radiopharmaceuticals Market Estimates and Projections by Region
12.1.1 Global PET Radiopharmaceuticals Sales Forecast by Regions 2021-2026
12.1.2 Global PET Radiopharmaceuticals Revenue Forecast by Regions 2021-2026
12.2 North America PET Radiopharmaceuticals Market Size Forecast (2021-2026)
12.2.1 North America: PET Radiopharmaceuticals Sales Forecast (2021-2026)
12.2.2 North America: PET Radiopharmaceuticals Revenue Forecast (2021-2026)
12.2.3 North America: PET Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
12.3 Europe PET Radiopharmaceuticals Market Size Forecast (2021-2026)
12.3.1 Europe: PET Radiopharmaceuticals Sales Forecast (2021-2026)
12.3.2 Europe: PET Radiopharmaceuticals Revenue Forecast (2021-2026)
12.3.3 Europe: PET Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific PET Radiopharmaceuticals Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: PET Radiopharmaceuticals Sales Forecast (2021-2026)
12.4.2 Asia Pacific: PET Radiopharmaceuticals Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: PET Radiopharmaceuticals Market Size Forecast by Region (2021-2026)
12.5 Latin America PET Radiopharmaceuticals Market Size Forecast (2021-2026)
12.5.1 Latin America: PET Radiopharmaceuticals Sales Forecast (2021-2026)
12.5.2 Latin America: PET Radiopharmaceuticals Revenue Forecast (2021-2026)
12.5.3 Latin America: PET Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa PET Radiopharmaceuticals Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: PET Radiopharmaceuticals Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: PET Radiopharmaceuticals Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: PET Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key PET Radiopharmaceuticals Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 PET Radiopharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. PET Radiopharmaceuticals Market Segments
Table 2. Ranking of Global Top PET Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global PET Radiopharmaceuticals Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of F-18
Table 5. Major Manufacturers of Ru-82
Table 6. Major Manufacturers of Others
Table 7. Global PET Radiopharmaceuticals Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global PET Radiopharmaceuticals Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global PET Radiopharmaceuticals Sales by Regions 2015-2020 (K Pcs)
Table 10. Global PET Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 11. Global PET Radiopharmaceuticals Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global PET Radiopharmaceuticals Sales by Manufacturers (2015-2020) (K Pcs)
Table 13. Global PET Radiopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 14. Global PET Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global PET Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PET Radiopharmaceuticals as of 2019)
Table 16. PET Radiopharmaceuticals Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. PET Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers PET Radiopharmaceuticals Price (2015-2020) (USD/Pcs)
Table 19. PET Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers PET Radiopharmaceuticals Product Type
Table 21. Date of International Manufacturers Enter into PET Radiopharmaceuticals Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global PET Radiopharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 24. Global PET Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 25. Global PET Radiopharmaceuticals Revenue by Type (2015-2020) (US$ Million)
Table 26. Global PET Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 27. PET Radiopharmaceuticals Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global PET Radiopharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 29. Global PET Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 30. North America PET Radiopharmaceuticals Sales by Country (2015-2020) (K Pcs)
Table 31. North America PET Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 32. North America PET Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 33. North America PET Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 34. North America PET Radiopharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 35. North America PET Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 36. North America PET Radiopharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 37. North America PET Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 38. Europe PET Radiopharmaceuticals Sales by Country (2015-2020) (K Pcs)
Table 39. Europe PET Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 40. Europe PET Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe PET Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 42. Europe PET Radiopharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 43. Europe PET Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 44. Europe PET Radiopharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 45. Europe PET Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific PET Radiopharmaceuticals Sales by Region (2015-2020) (K Pcs)
Table 47. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific PET Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific PET Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific PET Radiopharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 51. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific PET Radiopharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 53. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 54. Latin America PET Radiopharmaceuticals Sales by Country (2015-2020) (K Pcs)
Table 55. Latin America PET Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa PET Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America PET Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 58. Latin America PET Radiopharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 59. Latin America PET Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 60. Latin America PET Radiopharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 61. Latin America PET Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa PET Radiopharmaceuticals Sales by Country (2015-2020) (K Pcs)
Table 63. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa PET Radiopharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 67. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa PET Radiopharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 69. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 70. Cardinal Health Inc. (U.S.) Corporation Information
Table 71. Cardinal Health Inc. (U.S.) Description and Major Businesses
Table 72. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. Cardinal Health Inc. (U.S.) Product
Table 74. Cardinal Health Inc. (U.S.) Recent Development
Table 75. Mallinckrodt plc (Ireland) Corporation Information
Table 76. Mallinckrodt plc (Ireland) Description and Major Businesses
Table 77. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Mallinckrodt plc (Ireland) Product
Table 79. Mallinckrodt plc (Ireland) Recent Development
Table 80. GE Healthcare (U.K.) Corporation Information
Table 81. GE Healthcare (U.K.) Description and Major Businesses
Table 82. GE Healthcare (U.K.) PET Radiopharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. GE Healthcare (U.K.) Product
Table 84. GE Healthcare (U.K.) Recent Development
Table 85. Lantheus Medical Imaging, Inc. (U.S.) Corporation Information
Table 86. Lantheus Medical Imaging, Inc. (U.S.) Description and Major Businesses
Table 87. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Lantheus Medical Imaging, Inc. (U.S.) Product
Table 89. Lantheus Medical Imaging, Inc. (U.S.) Recent Development
Table 90. Bayer AG (Germany) Corporation Information
Table 91. Bayer AG (Germany) Description and Major Businesses
Table 92. Bayer AG (Germany) PET Radiopharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Bayer AG (Germany) Product
Table 94. Bayer AG (Germany) Recent Development
Table 95. Bracco Imaging S.p.A (Italy) Corporation Information
Table 96. Bracco Imaging S.p.A (Italy) Description and Major Businesses
Table 97. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Bracco Imaging S.p.A (Italy) Product
Table 99. Bracco Imaging S.p.A (Italy) Recent Development
Table 100. Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information
Table 101. Eczacibasi-Monrol Nuclear Products (Turkey) Description and Major Businesses
Table 102. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Eczacibasi-Monrol Nuclear Products (Turkey) Product
Table 104. Eczacibasi-Monrol Nuclear Products (Turkey) Recent Development
Table 105. Nordion, Inc. (Canada) Corporation Information
Table 106. Nordion, Inc. (Canada) Description and Major Businesses
Table 107. Nordion, Inc. (Canada) PET Radiopharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Nordion, Inc. (Canada) Product
Table 109. Nordion, Inc. (Canada) Recent Development
Table 110. Advanced Accelerator Applications S.A. (France) Corporation Information
Table 111. Advanced Accelerator Applications S.A. (France) Description and Major Businesses
Table 112. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Advanced Accelerator Applications S.A. (France) Product
Table 114. Advanced Accelerator Applications S.A. (France) Recent Development
Table 115. IBA Molecular Imaging (Belgium) Corporation Information
Table 116. IBA Molecular Imaging (Belgium) Description and Major Businesses
Table 117. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. IBA Molecular Imaging (Belgium) Product
Table 119. IBA Molecular Imaging (Belgium) Recent Development
Table 120. Global PET Radiopharmaceuticals Sales Forecast by Regions (2021-2026) (K Pcs)
Table 121. Global PET Radiopharmaceuticals Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global PET Radiopharmaceuticals Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: PET Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. North America: PET Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: PET Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Pcs)
Table 127. Europe: PET Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: PET Radiopharmaceuticals Sales Forecast by Region (2021-2026) (K Pcs)
Table 129. Asia Pacific: PET Radiopharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: PET Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Pcs)
Table 131. Latin America: PET Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: PET Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Pcs)
Table 133. Middle East and Africa: PET Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key PET Radiopharmaceuticals Players
Table 138. PET Radiopharmaceuticals Customers List
Table 139. PET Radiopharmaceuticals Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. PET Radiopharmaceuticals Product Picture
Figure 2. Global PET Radiopharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. F-18 Product Picture
Figure 4. Ru-82 Product Picture
Figure 5. Others Product Picture
Figure 6. Global PET Radiopharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Neurology
Figure 10. Others
Figure 11. PET Radiopharmaceuticals Report Years Considered
Figure 12. Global PET Radiopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 13. Global PET Radiopharmaceuticals Sales 2015-2026 (K Pcs)
Figure 14. Global PET Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global PET Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Figure 16. Global PET Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 17. Global PET Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 18. Global PET Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 19. Global PET Radiopharmaceuticals Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by PET Radiopharmaceuticals Revenue in 2019
Figure 21. PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global PET Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Figure 23. Global PET Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 24. Global PET Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
Figure 25. Global PET Radiopharmaceuticals Revenue Market Share by Type in 2019
Figure 26. Global PET Radiopharmaceuticals Market Share by Price Range (2015-2020)
Figure 27. Global PET Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 28. Global PET Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 29. Global PET Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
Figure 30. Global PET Radiopharmaceuticals Revenue Market Share by Application in 2019
Figure 31. North America PET Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America PET Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America PET Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 34. North America PET Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 35. U.S. PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America PET Radiopharmaceuticals Market Share by Type in 2019
Figure 40. North America PET Radiopharmaceuticals Market Share by Application in 2019
Figure 41. Europe PET Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe PET Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe PET Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 44. Europe PET Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 45. Germany PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe PET Radiopharmaceuticals Market Share by Type in 2019
Figure 56. Europe PET Radiopharmaceuticals Market Share by Application in 2019
Figure 57. Asia Pacific PET Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific PET Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 60. Asia Pacific PET Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 61. China PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific PET Radiopharmaceuticals Market Share by Type in 2019
Figure 84. Asia Pacific PET Radiopharmaceuticals Market Share by Application in 2019
Figure 85. Latin America PET Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America PET Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America PET Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 88. Latin America PET Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 89. Mexico PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America PET Radiopharmaceuticals Market Share by Type in 2019
Figure 96. Latin America PET Radiopharmaceuticals Market Share by Application in 2019
Figure 97. Middle East and Africa PET Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa PET Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 100. Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 101. Turkey PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa PET Radiopharmaceuticals Market Share by Type in 2019
Figure 108. Middle East and Africa PET Radiopharmaceuticals Market Share by Application in 2019
Figure 109. North America PET Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe PET Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific PET Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America PET Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa PET Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
診断用放射性医薬品・造影剤の世界市場（～2026年） Radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity. The contrast media plays an important role in enhancing the imaging facilities for better diagnosis. The market drivers are technology advancements in medical imaging, increasing demand for image guided procedures and…- 心臓核医学の世界市場（～2026年） Nuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular di…
- 改修心臓血管及び心臓病用機器の世界市場（～2026年） Market Analysis and Insights: Global Refurbished Cardiovascular & Cardiology Equipment Market The global Refurbished Cardiovascular & Cardiology Equipment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Refurbished Car…
- インターベンショナルカーディオロジー装置の世界市場（～2026年） Interventional cardiology is numerous non-surgical processes for treating cardiovascular related problems. These procedures use flexible tubes and catheters thin to get way inside blood vessels to perform diagnostic test or to repair heart structures or other damaged vessels, often evading the need …
- 心臓ポイントオブケア（POC）診断の世界市場（～2026年） Market Analysis and Insights: Global Cardiology Point-of-Care (POC) Diagnostics Market The global Cardiology Point-of-Care (POC) Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cardiology Point-of-Care (POC…